Renaissance Technologies’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-752,173
| Closed | -$6.54M | – | 3694 |
|
|
2018
Q2 | $6.54M | Buy |
752,173
+91,623
| +14% | +$824K | 0.01% | 1607 |
|
|
2018
Q1 | $6.7M | Buy |
660,550
+123,100
| +23% | +$1.03M | 0.01% | 1624 |
|
|
2017
Q4 | $2.61M | Buy |
537,450
+86,800
| +19% | +$422K | ﹤0.01% | 2183 |
|
|
2017
Q3 | $2.05M | Buy |
450,650
+49,050
| +12% | +$230K | ﹤0.01% | 2291 |
|
|
2017
Q2 | $2.03M | Buy |
401,600
+92,100
| +30% | +$412K | ﹤0.01% | 2258 |
|
|
2017
Q1 | $1.47M | Buy |
309,500
+55,200
| +22% | +$279K | ﹤0.01% | 2391 |
|
|
2016
Q4 | $1.42M | Buy |
254,300
+17,900
| +8% | +$98.3K | ﹤0.01% | 2387 |
|
|
2016
Q3 | $1.31M | Buy |
236,400
+16,500
| +8% | +$109K | ﹤0.01% | 2429 |
|
|
2016
Q2 | $1.54M | Buy |
219,900
+17,000
| +8% | +$120K | ﹤0.01% | 2346 |
|
|
2016
Q1 | $1.34M | Buy |
202,900
+15,300
| +8% | +$113K | ﹤0.01% | 2439 |
|
|
2015
Q4 | $1.93M | Buy |
187,600
+30,900
| +20% | +$358K | ﹤0.01% | 2136 |
|
|
2015
Q3 | $1.85M | Sell |
156,700
-30,176
| -16% | -$333K | ﹤0.01% | 2047 |
|
|
2015
Q2 | $1.71M | Buy |
186,876
+516
| +0.3% | +$3.9K | ﹤0.01% | 2160 |
|
|
2015
Q1 | $1.16M | Buy |
186,360
+75,354
| +68% | +$466K | ﹤0.01% | 2232 |
|
|
2014
Q4 | $622K | Buy |
111,006
+12,056
| +12% | +$70.2K | ﹤0.01% | 2358 |
|
|
2014
Q3 | $583K | Buy |
98,950
+4,200
| +4% | +$25.6K | ﹤0.01% | 2257 |
|
|
2014
Q2 | $649K | Sell |
94,750
-29,300
| -24% | -$196K | ﹤0.01% | 2214 |
|
|
2014
Q1 | $894K | Sell |
124,050
-40,200
| -24% | -$278K | ﹤0.01% | 2127 |
|
|
2013
Q4 | $1.09M | Sell |
164,250
-20,700
| -11% | -$141K | ﹤0.01% | 2043 |
|
|
2013
Q3 | $1.34M | Buy |
+184,950
| New | +$1.24M | ﹤0.01% | 1869 |
|
Renaissance Technologies's JNP Position: Q3 2018 in Review
Renaissance Technologies sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 752,173 shares — an estimated $6.54M sold.
Renaissance Technologies first reported a position in JNP in Q3 2013 and held it in 20 quarters. The position peaked at $6.7M in Q1 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.
- Renaissance Technologies reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
- Renaissance Technologies sold 752,173 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $6.54M.
- Renaissance Technologies first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and held it in 20 quarters.
- Renaissance Technologies's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $6.7M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.
Based on Renaissance Technologies's 13F filing for Q3 2018, filed 13 Nov 2018.